文献速递泌尿生殖腹部MR

双参数与多参数前列腺MRI评估包膜外侵犯的比较

Comparison of biparametric and multiparametric prostate MRI to assess extraprostatic tumor extension.
PubMed 文献 · Eur J Radiol · 2026-07-23

本研究回顾性纳入90例活检前接受mpMRI并随后行根治性前列腺切除术的患者,以组织病理为参考标准,比较bpMRI与mpMRI检测前列腺癌包膜外侵犯的诊断效能。结果显示两种方案在形态学特征、评分系统AUC方面均无显著差异,支持bpMRI作为局部分期的替代方案。

要点

  • bpMRI与mpMRI对前列腺包膜外侵犯检出效能相当,可减少DCE依赖。
  • MRI可见包膜破裂具有很高特异度但敏感度低,报告时需注意假阴性。
  • 评分系统最优阈值为2/6分,bpMRI与mpMRI均适用。

核心结论

  • bpMRI与mpMRI在检测前列腺癌包膜外侵犯方面诊断准确性无显著差异,支持bpMRI作为局部分期的替代方案。

研究设计与样本

  • 回顾性研究,纳入90例活检前接受mpMRI后行根治性前列腺切除术的男性,平均年龄64±6岁。
  • 由4名放射科医师独立评估bpMRI(T2WI、DWI)与mpMRI(增加DCE),以组织病理为参考标准。

关键影像表现/征象

  • 评估的影像形态特征包括假包膜膨隆、假包膜不规则、MRI可见包膜破裂及假包膜肿瘤接触长度。
  • MRI可见包膜破裂在bpMRI与mpMRI中敏感度分别为0.22与0.23,特异度均为0.99。

诊断标准与关键数值

  • MRI可见包膜破裂bpMRI敏感度0.22(95%CI:0.15,0.31),mpMRI敏感度0.23(95%CI:0.16,0.31),p=0.87。
  • MRI可见包膜破裂bpMRI特异度0.99(95%CI:0.96,0.99),mpMRI特异度0.99(95%CI:0.96,0.99),p=1.00。
  • 评分系统bpMRI平均AUC为0.80(95%CI:0.69,0.90),mpMRI平均AUC为0.79(95%CI:0.69,0.90),p=0.77。
  • 评分系统最优阈值为2/6分,两种方案一致;评分整合形态特征并将MRI可见包膜破裂和肿瘤接触长度加权双倍。
  • 86例(95.6%)患者为临床有意义前列腺癌(ISUP≥2)。

临床应用与阅片要点

  • bpMRI可作为前列腺癌局部分期手段,减少不必要DCE序列和造影剂使用。
  • 阅片时应综合假包膜膨隆、不规则、破裂及接触长度进行评分,而非单独依赖单一征象。
  • MRI可见包膜破裂特异度极高但敏感度低,阴性时不能完全排除包膜外侵犯。

局限性

  • 研究为回顾性设计,可能存在选择偏倚。
  • 未提供研究开展中心数量及MRI设备与序列具体参数。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Accurate assessment of extraprostatic extension (EPE) in prostate cancer is essential for surgical planning. This study aimed to compare the diagnostic performance of biparametric (bpMRI) and multiparametric MRI (mpMRI) for detecting EPE using histopathology as the reference standard.

MATERIALS AND METHODS: Biopsy-naïve men that underwent mpMRI followed by radical prostatectomy were included retrospectively. Four radiologists independently evaluated bpMRI (T2-weighted, diffusion-weighted) and mpMRI (addition of DCE). PI-RADS, pseudocapsular (PC) bulging, PC irregularity, MRI-visible PC breach, and PC tumor contact length were assessed. Histopathological prostatectomy specimens served as reference. Sensitivities and specificities were calculated using generalized estimating equations. A scoring system, integrating these morphological characteristics with MRI-visible PC breach and tumor contact length weighted double, was evaluated by calculating the area-under-the-curve (AUC) and Youden-Index.

RESULTS: 90 men (mean age: 64 ± 6) were included. 86 (95.6%) patients had clinically significant prostate cancer (ISUP ≥ 2). bpMRI and mpMRI had no significant difference regarding morphological characteristics, for instance, MRI-visible PC breach (sensitivity: 0.22 [95% CI: 0.15, 0.31] versus 0.23 [95% CI: 0.16, 0.31], p = 0.87; specificity: 0.99 [95% CI: 0.96, 0.99] versus 0.99 [95% CI: 0.96, 0.99], p = 1.00). The AUC for the scoring system was similar between bpMRI and mpMRI (mean AUC: 0.80 [95% CI: 0.69, 0.90] versus 0.79 [95% CI: 0.69, 0.90], p = 0.77) with an optimal score of 2/6 points for both protocols.

CONCLUSION: Diagnostic accuracy for detecting EPE did not differ between bpMRI and mpMRI, thus supporting bpMRI as an alternative for local prostate cancer staging.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Bischoff, Schmidt, Endler, et al. Comparison of biparametric and multiparametric prostate MRI to assess extraprostatic tumor extension. Eur J Radiol. 2026. PMID: 42520381. doi:10.1016/j.ejrad.2026.113110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。